Luminex Corporation

12212 Technology Boulevard
Austin,  TX  78727

United States
http://www.luminexcorp.com

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We serve the needs of our customers in diverse markets including clinical diagnostics, pharmaceutical drug discovery, life science research, immunology, and personalized medicine. Our goal is to transform global healthcare with innovative instruments and assays that deliver cost-effective, rapid results to clinicians and researchers. For further information, please visit www.luminexcorp.com/.

Brands: https://www.luminexcorp.com/wp-content/uploads/2020/11/TS290545.AACC_.500x500.Flex_.png


 Videos

  • <iframe width="560" height="315" src="https://www.youtube.com/embed/vpqviKlIrPQ" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>

 Corporate, Product or Service Images


 Products

  • VERIGENE® II Respiratory Flex + SARS-CoV-2 Assay
    Discover how the VERIGENE® II Respiratory Flex + SARS-CoV-2 Assay (EUA) can deliver simple, fast, and comprehensive detection of infectious respiratory diseases and pathogens. This assay is under development and is not currently FDA Cleared/FDA Authorized/CE Marked....

  • The VERIGENE® II Respiratory Flex + SARS-CoV-2 Assay (EUA) is being designed to detect the most common viral and bacterial respiratory pathogens, including SARS-CoV-2. Using the sample-to-answer VERIGENE® ll System, extraction, PCR, and detection all take place in the self-contained cassette. Discover how the VERIGENE II Respiratory Flex + SARS-CoV-2 Assay (EUA) can deliver simple, fast, and comprehensive detection of infectious respiratory diseases and pathogens.

    This assay is under development and is not currently FDA Cleared/FDA Authorized/CE Marked.

  • VERIGENE® II Gastrointestinal Flex Assay
    Discover how the VERIGENE® II Gastrointestinal Flex Assay can support cost-effective, rapid detection of GI pathogens and help improve patient outcomes. This assay is under development and not currently FDA Cleared/FDA Authorized/CE Marked. ...

  • The Gastrointestinal Flex Assay (IVD) in development for use on the VERIGENE® II sample-to-answer system—offers Flex® Testing for pathogens associated with gastroenteritis, and features 24 GI targets, including bacteria, viruses, and parasites. Discover how the VERIGENE® II Gastrointestinal Flex Assay can support cost-effective, rapid detection of GI pathogens and help improve patient outcomes.

    This assay is under development and not currently FDA Cleared/FDA Authorized/CE Marked.